>>> US Gapping down

Gapping down
In reaction to earnings/guidance:
  • TDOC -18.7% (also withdraws guidance), ATEC -18.3%, ATUS -17.2%, UDMY -16.8% (also announces cost saving measures), LAB -13.8% (also CFO to resign), TENB -13%, CFLT -12.2%, MRNA -11%, NGVT -10.7% (also to advance repositioning and improve profitability of its Performance Chemicals segment), AUR -10.5% (also commences $350 mln stock offering; also cancels business review conference call), MBLY -9.5%, SPNS -9.3%, VNT -9%, ARM -8.7%, MYRG -8.3%, WCC -8%, ACLS -7.4%, PTVE -7.1%, RGR -6.9%, TM -6.6%, CROX -6.5%, SON -5.4%, TS -5.2%, AGIO -5.2%, CTVA -5% (also CFO to retire, names new CFO; also plans to buyback $1 bln of shares in FY24), W -4.9%, CCRN -4.8%, DNLI -4.8%, HSY -4.5%, NRDS -4.3%, HST -4.2% (also acquires hotel), INVA -4.1%, WDC -4%, BBSI -4%, INMD -3.9%, CNMD -3.4%, EXK -3.3%, GEL -3.2%, MGM -3.1%, CRBG -3%, ALB -2.9% (also launches review of cost and operating structure; includes announces actions on Kemerton site in Australia), APLS -2.8%, MDXG -2.7%, CGNX -2.7%, SAVE -2.7%, BALL -2.7%, GKOS -2.6%, ETSY -2.6% (also CFO to retire), BDX -2.6%, APO -2.6%, MT -2.5%, ECVT -2.5%, SCI -2.4%, APPN -2.4%, LRCX -2.3%, HLF -2.3%, ALKT -2.3%, TRI -2.2%, AME -2.2%, PBF -2.1%, VAC -1.9%, ING -1.9%, AG -1.8%, SUI -1.7%, AIG -1.6%, BDC -1.5%, IR -1.4%, FICO -1.3%, BALY -1.3%, MTG -1.3%, IEX -1.3%, KGC -1.2%, CI -1.2%, ENVX -1% (also signs deal with EV OEM; also signs collaboration to provide silicon batteries for IoT product category), PACK -1%
Other news:
  • ALXO -31% (reports topline data from ASPEN-06 Phase 2 Trial)
  • AGIO -5.2% (topline results from the global Phase 3 ACTIVATE-KidsT study)
  • HES -3.9% (CVX and HES remain committed to merger)
  • SGH -3.2% ($150 mln convertible notes offering)
  • VALN -3% (Valneva SE and LimmaTech enter into a strategic partnership to accelerate the development of the world's most clinically advanced tetravalent shigella vaccine candidate)
  • OCGN -2.5% (prices offering of 30,434,783 shares of its common stock at $1.15 per share)
Analyst comments:
  • ETSY -1.8% (downgraded to Perform from Outperform at Oppenheimer)
  • BILL -1.7% (downgraded to Peer Perform from Outperform at Wolfe Research)